Becton Dickinson & Co
Close on Nov 18, 2026Market cap $58.86BP/E 65.3Yield 1.93%
Becton Dickinson ClinicalTrials.gov Newly Started Clinical Studies by Year
ClinicalTrials.gov Newly Started Clinical Studies — BD & C.R. Bard
Becton Dickinson ClinicalTrials.gov Newly Started Clinical Studies: 10 in FY2026, up 66.7% from a year earlier. That is the highest of the 12 years on record here.
Where the FY2026 figure comes from
Source: NIH ClinicalTrials.gov Registry — Becton Dickinson & C.R. Bard ↗
Reported in NIH ClinicalTrials.gov API v2 (Lead-Sponsor BD & C.R. Bard Studies).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up clinicalTrials.gov Newly Started Clinical Studies
Cite this data
StockData. (2026). Becton Dickinson ClinicalTrials.gov Newly Started Clinical Studies, annual FY2015–FY2026 [Data set]. Compiled from Becton Dickinson SEC filings and investor materials. https://stockdatahq.com/stocks/bdx/kpis/ext-ct-started
See every metric in the Becton Dickinson KPI table. Data updated Nov 7, 2026.
See a number that looks wrong?